1,299 results on '"Schoen, Robert E."'
Search Results
102. Supplementary Data and Supplementary Tables 1 and 2 from Genetic Predictors of Circulating 25-Hydroxyvitamin D and Risk of Colorectal Cancer
103. Supplementary Data from BET Inhibitors Potentiate Chemotherapy and Killing of SPOP-Mutant Colon Cancer Cells via Induction of DR5
104. Data from Gene–Environment Interaction Involving Recently Identified Colorectal Cancer Susceptibility Loci
105. Supplementary Figures S1-S2 from Evaluation of Colon Cancer–Specific Antigen 2 as a Potential Serum Marker for Colorectal Cancer
106. Supplementary Material: Funding, Acknowledgements, Consortia, and Bioinformatics Tools Funding sources from Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
107. Data from Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility Loci
108. Supplementary Table 4 from Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility Loci
109. Supplementary Table 6 from Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility Loci
110. Supplementary Table 3 from Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility Loci
111. Supplementary Table 2 from Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility Loci
112. Supplementary Table 5 from Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility Loci
113. Supplementary Figures 1-2 from Initial Analyses of Colon Cancer–Specific Antigen (CCSA)-3 and CCSA-4 as Colorectal Cancer–Associated Serum Markers
114. Supplementary Table 1 from Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility Loci
115. Supplementary Figure 1 from Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility Loci
116. Supplementary Table 7 from Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility Loci
117. Low-Carbohydrate Diet Score and the Risk of Colorectal Cancer: Findings from the Singapore Chinese Health Study
118. Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival
119. Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma
120. Leisure time sedentary behaviour and risks of breast, colorectal, and prostate cancer: A Mendelian randomization analysis
121. Genome-wide Interaction Study with Smoking for Colorectal Cancer Risk Identifies Novel Genetic Loci Related to Tumor Suppression, Inflammation, and Immune Response
122. Combining Asian-European Genome-Wide Association Studies of Colorectal Cancer Improves Risk Prediction Across Race and Ethnicity
123. Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
124. Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease
125. Targeting p53-dependent stem cell loss for intestinal chemoprotection
126. Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas.
127. Differential expression of circulating microRNAs according to severity of colorectal neoplasia
128. Abstract IA016: Lessons learned from clinical trials of MUC1 peptide vaccines for cancer prevention
129. Clinical and Genomic Characterization of Interval Colorectal Cancer in 3 Prospective Cohorts
130. Abstract IA005: Risk prediction in colorectal cancer screening: Reflections on the current status
131. Abstract A010: Molecular characteristics and prognosis of early-onset colorectal cancer according to detailed anatomical locations: Comparison to later-onset cases
132. Body mass index and molecular subtypes of colorectal cancer
133. 15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality
134. Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses
135. Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma
136. Dietary Nonstarch Polysaccharide Intake and Risk of Colorectal Cancer: Findings from the Singapore Chinese Health Study
137. BID mediates selective killing of APC-deficient cells in intestinal tumor suppression by nonsteroidal antiinflammatory drugs
138. Association Between Telephone Activity and Features of Patients With Inflammatory Bowel Disease
139. Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
140. Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?
141. Low-Carbohydrate Diet Score and the Risk of Colorectal Cancer: Findings from the Singapore Chinese Health Study.
142. A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1
143. Occurrence of Distal Colorectal Neoplasia Among Whites and Blacks Following Negative Flexible Sigmoidoscopy: An Analysis of PLCO Trial
144. Abstract 3666: Dietary potassium and risk of colorectal cancer: Findings from the Singapore Chinese Cohort Study
145. Abstract 1930: Unsupervised sub-cellular segmentation of complex tissue and cell samples using highly multiplexed imaging-derived a priori knowledge
146. Abstract 735: Low-carbohydrate diet score and the risk of colorectal cancer: Findings from a prospective cohort study
147. Five- or 10-year colonoscopy for 1-2 non-advanced adenomatous polyps (FORTE) NRG-CC005 study: A randomized phase III non-inferiority trial comparing colorectal cancer incidence in participants with 1-2 non-advanced adenomas randomized to a 5- and 10-year surveillance colonoscopy exam schedule versus a 10-year surveillance colonoscopy exam schedule.
148. Genome-Wide Interaction Analysis of Genetic Variants With Menopausal Hormone Therapy for Colorectal Cancer Risk
149. 785: CLINICAL AND GENOMIC CHARACTERIZATION OF INTERVAL COLORECTAL CANCER IN THREE PROSPECTIVE COHORTS
150. Relationship Between Detection of Adenomas by Flexible Sigmoidoscopy and Interval Distal Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.